Related Experiment Videos
Neonatal polycythemia and hyperviscosity
1Division of Pediatric Hematology/Oncology, Eastern Virginia Medical School, Norfolk, USA.
Clinics in Perinatology
|September 1, 1995
Summary
Neonatal polycythemia/hyperviscosity syndrome is common but often asymptomatic. While partial exchange transfusion can improve symptoms, it does not significantly alter long-term outcomes for affected infants.
Area of Science:
- Neonatology
- Pediatric Hematology
Background:
- Neonatal polycythemia/hyperviscosity syndrome affects 1-5% of newborns.
- Significant symptoms are often linked to predisposing factors like perinatal asphyxia, intrauterine hypoxia, or hypoglycemia.
- Infants small for gestational age and those with maternal gestational diabetes are at increased risk.
Purpose of the Study:
- To review the clinical presentation and management of neonatal polycythemia/hyperviscosity syndrome.
- To evaluate the efficacy of partial exchange transfusion in improving neonatal outcomes.
Main Methods:
- Review of existing literature on neonatal polycythemia/hyperviscosity syndrome.
- Analysis of the effects of partial exchange transfusion on hematocrit and viscosity.
- Assessment of symptom amelioration and long-term outcomes post-intervention.
Main Results:
- Partial exchange transfusion effectively lowers hematocrit and viscosity.
- The procedure can reverse physiological abnormalities and alleviate most symptoms.
- Long-term outcome improvements following partial exchange transfusion have not been demonstrated.
Conclusions:
- Partial exchange transfusion is a viable symptomatic treatment for neonatal polycythemia/hyperviscosity syndrome.
- The lack of demonstrated long-term benefits necessitates further research into optimal management strategies.
- Identifying and managing predisposing factors remains crucial for infant health.